Business Description
Lifevantage Corp
NAICS : 311999
SIC : 2099
ISIN : US53222K2050
Compare
Compare
Traded in other countries / regions
LFVN.USAL2T1.Germany IPO Date
2013-03-28Description
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.09 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.48 | |||||
| Debt-to-EBITDA | 1.39 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 5.34 | |||||
| Beneish M-Score | -2.14 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -27.8 | |||||
| 3-Year EPS without NRI Growth Rate | -35 | |||||
| 3-Year FCF Growth Rate | -4.4 | |||||
| 3-Year Book Growth Rate | -8.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 88.38 | |||||
| 9-Day RSI | 80.73 | |||||
| 14-Day RSI | 75.26 | |||||
| 6-1 Month Momentum % | 104.84 | |||||
| 12-1 Month Momentum % | 133.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.76 | |||||
| Quick Ratio | 0.99 | |||||
| Cash Ratio | 0.66 | |||||
| Days Inventory | 139.38 | |||||
| Days Sales Outstanding | 4.8 | |||||
| Days Payable | 56.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.79 | |||||
| Dividend Payout Ratio | 0.47 | |||||
| Forward Dividend Yield % | 0.84 | |||||
| 5-Year Yield-on-Cost % | 0.79 | |||||
| 3-Year Average Share Buyback Ratio | 2.8 | |||||
| Shareholder Yield % | 4.48 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 79.21 | |||||
| Operating Margin % | 3.14 | |||||
| Net Margin % | 2.11 | |||||
| FCF Margin % | 2.78 | |||||
| ROE % | 15.08 | |||||
| ROA % | 6.62 | |||||
| ROIC % | 15.94 | |||||
| ROC (Joel Greenblatt) % | 33.06 | |||||
| ROCE % | 15.56 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 55.78 | |||||
| Forward PE Ratio | 26.45 | |||||
| PE Ratio without NRI | 55.78 | |||||
| Shiller PE Ratio | 36.11 | |||||
| PS Ratio | 1.17 | |||||
| PB Ratio | 8.04 | |||||
| Price-to-Tangible-Book | 8.13 | |||||
| Price-to-Free-Cash-Flow | 42.81 | |||||
| Price-to-Operating-Cash-Flow | 33.55 | |||||
| EV-to-EBIT | 36.14 | |||||
| EV-to-EBITDA | 23.13 | |||||
| EV-to-Revenue | 1.13 | |||||
| EV-to-FCF | 41.27 | |||||
| Price-to-Projected-FCF | 1.95 | |||||
| Price-to-Median-PS-Value | 2.47 | |||||
| Price-to-Graham-Number | 4.48 | |||||
| Price-to-Net-Current-Asset-Value | 44.39 | |||||
| Earnings Yield (Greenblatt) % | 2.77 | |||||
| FCF Yield % | 2.41 | |||||
| Forward Rate of Return (Yacktman) % | -18.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lifevantage Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 179.721 | ||
| EPS (TTM) (€) | 0.293 | ||
| Beta | -0.45 | ||
| Volatility % | 78.92 | ||
| 14-Day RSI | 75.26 | ||
| 14-Day ATR (€) | 0.577944 | ||
| 20-Day SMA (€) | 14.82 | ||
| 12-1 Month Momentum % | 133.03 | ||
| 52-Week Range (€) | 4.88 - 18.2 | ||
| Shares Outstanding (Mil) | 12.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lifevantage Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lifevantage Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lifevantage Corp Frequently Asked Questions
What is Lifevantage Corp(FRA:L2T1)'s stock price today?
The current price of FRA:L2T1 is €18.20. The 52 week high of FRA:L2T1 is €18.20 and 52 week low is €4.88.
When is next earnings date of Lifevantage Corp(FRA:L2T1)?
The next earnings date of Lifevantage Corp(FRA:L2T1) is 2025-01-30 Est..
Does Lifevantage Corp(FRA:L2T1) pay dividends? If so, how much?
The Dividend Yield %  of Lifevantage Corp(FRA:L2T1) is 0.79% (As of Today), Highest Dividend Payout Ratio of Lifevantage Corp(FRA:L2T1) was 0.58. The lowest was 0.08. And the median was 0.52. The  Forward Dividend Yield % of Lifevantage Corp(FRA:L2T1) is 0.84%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers